588
Views
36
CrossRef citations to date
0
Altmetric
Drug Evaluations

Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest

Pages 1147-1157 | Published online: 03 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Luis Bahamondes, Josefina Lira-Plascencia, Ricardo Martin, Victor Marin & Maria Y Makuch. (2015) Knowledge and attitudes of Latin American gynecologists regarding unplanned pregnancy and use of combined oral contraceptives. International Journal of Women's Health 7, pages 485-491.
Read now
Regine Sitruk-Ware & Anita Nath. (2015) Applying emerging science to contraception research: implications for the clinic. Expert Review of Endocrinology & Metabolism 10:1, pages 115-126.
Read now
Anne Burke. (2013) Nomegestrol acetate-17b-estradiol for oral contraception. Patient Preference and Adherence 7, pages 607-619.
Read now
Giuseppe Bifulco, Attilio Di Spiezio Sardo, Nicoletta De Rosa, Elena Greco, Marialuigia Spinelli, Costantino Di Carlo, Giovanni A. Tommaselli & Carmine Nappi. (2012) The use of an oral contraceptive containing estradiol valerate and dienogest before office operative hysteroscopy: a feasibility study. Gynecological Endocrinology 28:12, pages 949-955.
Read now
Jessica W Kiley & Lee P Shulman. (2011) Estradiol valerate and dienogest: a new approach to oral contraception. International Journal of Women's Health 3, pages 281-286.
Read now
Luis Bahamondes, Ilza Monteiro & Arlete Fernandes. (2010) Treatment of heavy menstrual bleeding with a new combination of estradiol valerate and dienogest. Open Access Journal of Contraception 1, pages 119-126.
Read now

Articles from other publishers (30)

Esmeralda Hidalgo-Lopez, Isabel Noachtar & Belinda Pletzer. (2023) Hormonal contraceptive exposure relates to changes in resting state functional connectivity of anterior cingulate cortex and amygdala. Frontiers in Endocrinology 14.
Crossref
Anna CAPOZZI, Giovanni SCAMBIA & Stefano LELLO. (2022) Clinical pharmacology of progestins. Minerva Obstetrics and Gynecology 74:4.
Crossref
Corinne LaVasseur, Suvi Neukam, Thomas Kartika, Bethany Samuelson Bannow, Joseph Shatzel & Thomas G. DeLoughery. (2022) Hormonal therapies and venous thrombosis: Considerations for prevention and management. Research and Practice in Thrombosis and Haemostasis 6:6, pages e12763.
Crossref
Nisha Verma, Carrie Cwiak & Andrew M. Kaunitz. (2021) Hormonal Contraception: Systemic Estrogen and Progestin Preparations. Clinical Obstetrics & Gynecology 64:4, pages 721-738.
Crossref
Julia Bartley & Ingeborg Voss-Heine. (2021) Blutungsstörungen, Dysmenorrhö und Endometriose im JugendalterBleeding disorders, dysmenorrhea and endometriosis in adolescence. Der Gynäkologe 54:9, pages 640-649.
Crossref
Bernd Kleine-Gunk. (2021) Erstes orales Kontrazeptivum mit Estetrol zugelassen. gynäkologie + geburtshilfe 26:4, pages 29-31.
Crossref
A. Cattoni, F. Parissone, I. Porcari, S. Molinari, N. Masera, M. Franchi, S. Cesaro, R. Gaudino, P. Passoni & A. Balduzzi. (2021) Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations. Blood Reviews 45, pages 100730.
Crossref
Claudia Borzutzky & Julie Jaffray. (2020) Diagnosis and Management of Heavy Menstrual Bleeding and Bleeding Disorders in Adolescents. JAMA Pediatrics 174:2, pages 186.
Crossref
Ю. Г. Антипкін, В. В. Камінський & Т. Ф. Татарчук. (2017) Optimization of family planning service in Ukraine in the realization of modern strategy of woman health maintenance. REPRODUCTIVE ENDOCRINOLOGY:35, pages 7-16.
Crossref
Amanda Black, Edith Guilbert, Dustin Costescu, Sheila Dunn, William Fisher, Sari Kives, Melissa Mirosh, Wendy V. Norman, Helen Pymar, Robert Reid, Geneviève Roy, Hannah Varto, Ashley Waddington, Marie-Soleil Wagner & Anne Marie Whelan. (2017) No 329-Consensus canadien sur la contraception (4e partie de 4) : chapitre 9 – contraception hormonale combinée. Journal of Obstetrics and Gynaecology Canada 39:4, pages 269-314.e5.
Crossref
Amanda Black, Edith Guilbert, Dustin Costescu, Sheila Dunn, William Fisher, Sari Kives, Melissa Mirosh, Wendy V. Norman, Helen Pymar, Robert Reid, Geneviève Roy, Hannah Varto, Ashley Waddington, Marie-Soleil Wagner & Anne Marie Whelan. (2017) No. 329-Canadian Contraception Consensus Part 4 of 4 Chapter 9: Combined Hormonal Contraception. Journal of Obstetrics and Gynaecology Canada 39:4, pages 229-268.e5.
Crossref
Regine Sitruk-Ware. (2016) Hormonal contraception and thrombosis. Fertility and Sterility 106:6, pages 1289-1294.
Crossref
T. Yu. Pestrikova, E. L. Suhonosova & E. A. Yurasova. (2016) The effectiveness of contraceptive containing estradiol valerate in combination with dienogest in patients with polycystic ovary syndrome. Problemy reproduktsii 22:3, pages 115.
Crossref
Rebecca H. Allen, Andrew M. Kaunitz & Martha Hickey. 2016. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology 664 693 .
Maureen K. Baldwin & Jeffrey T. Jensen. (2013) Contraception during the perimenopause. Maturitas 76:3, pages 235-242.
Crossref
Vincenzo De Leo, Franca Fruzzetti, Maria Concetta Musacchio, Valeria Scolaro, Alessandra Di Sabatino & Giuseppe Morgante. (2013) Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism. Contraception 88:3, pages 364-368.
Crossref
Lee P Shulman. (2013) Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24/4 regimen. Journal of Family Planning and Reproductive Health Care 39:3, pages 211-216.
Crossref
Regine Sitruk-Ware & Anita Nath. (2013) Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills. Best Practice & Research Clinical Endocrinology & Metabolism 27:1, pages 13-24.
Crossref
Hatem Abu Hashim. (2012) Medical treatment of idiopathic heavy menstrual bleeding. What is new? An evidence based approach. Archives of Gynecology and Obstetrics 287:2, pages 251-260.
Crossref
F. Trémollieres. (2012) Contraception orale estro-progestative : quelle différence entre éthinylestradiol et estradiol ?. Gynécologie Obstétrique & Fertilité 40:2, pages 109-115.
Crossref
Laura M. Borgelt & Chad W. Martell. (2012) Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive. Clinical Therapeutics 34:1, pages 37-55.
Crossref
Huib AAM Van Vliet, Marjolein Raps, Laureen M Lopez & Frans M Helmerhorst. (2011) Quadriphasic versus monophasic oral contraceptives for contraception. Cochrane Database of Systematic Reviews.
Crossref
Salvatore Caruso, Carmela Agnello, Mattea Romano, Stefano Cianci, Lucia Lo Presti, Chiara Malandrino & Antonio Cianci. (2011) Preliminary Study on the Effect of Four-phasic Estradiol Valerate and Dienogest (E2V/DNG) Oral Contraceptive on the Quality of Sexual Life. The Journal of Sexual Medicine 8:10, pages 2841-2850.
Crossref
Johannes Bitzer & James A. Simon. (2011) Current issues and available options in combined hormonal contraception. Contraception 84:4, pages 342-356.
Crossref
Lee P. Shulman. (2011) The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives. American Journal of Obstetrics and Gynecology 205:4, pages S9-S13.
Crossref
Regine Sitruk-Ware & Anita Nath. (2011) Metabolic effects of contraceptive steroids. Reviews in Endocrine and Metabolic Disorders 12:2, pages 63-75.
Crossref
Thomas G. DeLoughery. (2011) Estrogen and thrombosis: Controversies and common sense. Reviews in Endocrine and Metabolic Disorders 12:2, pages 77-84.
Crossref
Huib AAM Van Vliet, Marjolein Raps, Laureen M Lopez & Frans M Helmerhorst. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Sung Chul LimMoon Jin JeongSe Eun KimSeung Hyun KimSam Cheol KimSeung-Yong SeoTak KimSeong Soo KangChun Sik Bae. (2011) Histologic comparison of polycystic ovary syndrome induced by estradiol valerate and letrozole. Korean Journal of Obstetrics 54:6, pages 294.
Crossref
Lisa M Keder. (2011) A New Estradiol-Dienogest Oral Contraceptive Marks “The Pill's” 50th Anniversary. American Journal of Therapeutics 18:1, pages 38-44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.